Arrivent Biopharma: Truist Securities cuts target price to $18 from $45
AVBP•Truist Securities cut its target price for Arrivent Biopharma to $18 from $45.
Related News
Corning declares quarterly dividend of $0.28 a share
GLW•
OneSpan to host webinar on Digital Agreements evolution for financial institutions
OSPN•
Nano Nuclear to join TD Cowen nuclear roundtable fireside chat
NNE•
DXC unveils insurance platform upgrades at Connect Insurance Executive Forum in London
DXC•
Toyo plans to complete HJT cell line in Texas in Q1 2028
TOYO•